Skip to main content

Uitentuis SE, Bambach C, Elshot YS, et al.
Dermatol Surg (2022)

Open AccessJC: December 2022

This retrospective cohort study compared survival outcomes of Merkel cell carcinoma (MCC) treated with Mohs micrographic surgery versus wide local excision (WLE). The analysis evaluated local recurrence, distant recurrence, and overall survival. Results showed comparable or superior outcomes with Mohs compared to WLE, suggesting that Mohs is a viable surgical approach for MCC, particularly for tumors where tissue conservation is important. The study contributes to the growing evidence supporting Mohs as an alternative to wide excision for this aggressive neuroendocrine carcinoma.

Take-Home Messages

  • Mohs surgery demonstrates comparable or superior local recurrence rates versus WLE for Merkel cell carcinoma.
  • Mohs offers the advantage of complete margin assessment with maximal tissue conservation in MCC.
  • MCC treatment decisions should integrate surgical approach with sentinel lymph node biopsy and consideration of adjuvant therapy.

Topic

Mohs Technique & Outcomes

Mohs micrographic surgery indications, outcomes, and procedural refinements

Related MohsPedia Articles

Abstract

When treating Merkel cell carcinoma (MCC), the relation between wide local excision (WLE) margin and recurrence or survival is unclear. Mohs micrographic surgery (MMS) is an alternative surgical option for MCC, but it is unknown whether the local recurrence rate differs between MMS and WLE. To systematically assess the available literature to determine the recurrence and survival rates when treating MCC with MMS and different clinical excision margins. The MEDLINE, EMBASE, and CENTRAL database

Literature review only. This summary is an editorial interpretation and may not reflect the complete findings of the original publication. Always refer to the full-text article for clinical decision-making.